安琪酵母(600298.SH):擬實施園區工廠年產1.8萬噸複合微生物綠色製造項目(一期)
格隆匯12月17日丨安琪酵母(600298.SH)公佈,為進一步公司在釀造及生物能源領域的穩步發展,提升公司釀造製品生產線機械化和自動化程度,公司擬在宜昌生物產業園新建年產1.8萬噸複合微生物綠色製造項目(一期)(簡稱:項目)。項目金額預計1.44億元人民幣。
建設內容:項目計劃建設一個釀造復配車間和一個固態發酵原料車間,總面積約8800平方米。固態發酵車間主體設備一期採用圓盤機固態發酵和乾燥,二期增加流化牀沸騰乾燥,釀造復配車間主體設備為真空上料機、混合機和包裝機,原料儲存和週轉設計為普通平庫,並提高自動化設計,降低勞動強度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.